This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, C. C. W. Articles by Ho, P. C. Search for Related Content PubMed PubMed Citation Articles by Chan, C. C. W. Articles by Ho, P. C. Related Collections Female Endocrinology

A Prospective, Randomized, Double-Blind Study to Compare Two Doses of Recombinant Human Chorionic Gonadotropin in Inducing Final Oocyte Maturity and the Hormonal Profile during the Luteal Phase

Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China

Address all correspondence and requests for reprints to: Dr. Carina C. W. Chan, Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong SAR, China. E-mail: cwcchan{at}graduate.hku.hk.

Context: Different doses of human chorionic gonadotropin (hCG) have been used in various in vitro fertilization (IVF) treatment protocols to achieve final oocyte maturation. There is as yet no agreement on the optimum dose required.

Objectives: The objective of this study was to compare the effectiveness of 250 and 500 µg recombinant hCG (r-hCG), which represented the lower and upper limits of the dose range, in inducing final oocyte maturation during IVF and intracytoplasmic sperm injection cycles.

Design: This was a prospective, randomized, double-blind study.

Setting: This study was performed at an IVF clinic in a teaching hospital.

Patients: Sixty patients with an indication for intracytoplasmic sperm injection were studied.

Intervention: The treatment dose used was 250 or 500 µg r-hCG.

Main Outcome Measures: The percentage of metaphase II oocytes retrieved per patient, as an indicator of oocyte maturation, and the hormone profiles of the treatment cycle starting from the day of hCG up to hCG+10 d were the main outcome measures.

Results: The percentage of metaphase II oocytes was similar in the two groups (89.3% vs. 86.0%; P = 0.326) despite higher serum and follicular fluid hCG levels on hCG+2 and hCG+4 d, as was the follicular fluid to serum hCG ratio in the 500-µg r-hCG group. Serum estradiol and progesterone levels were comparable initially, but became significantly higher in the 500-µg r-hCG group on hCG+10 d.

Conclusion: The two doses of r-hCG were equally effective in inducing final oocyte maturation. It remains unclear whether the higher midluteal estradiol and progesterone levels in the 500-µg r-hCG group confer any benefit.

This article has been cited by other articles:

				N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization Endocr. Rev., April 1, 2006; 27(2): 170 - 207. [Abstract] [Full Text] [PDF]

				E. H. Y. Ng, C. C. W. Chan, O. S. Tang, W. S. B. Yeung, and P. C. Ho Factors affecting endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound during IVF treatment Hum. Reprod., April 1, 2006; 21(4): 1062 - 1069. [Abstract] [Full Text] [PDF]

				C. C.W. Chan and E. H.Y. Ng Is 250 {micro}g rHCG always better and safer than 500 {micro}g rHCG? Hum. Reprod., February 1, 2006; 21(2): 569 - 570. [Full Text] [PDF]

				C.C.W. Chan, V.W.S. Liu, E.Y.L. Lau, W.S.B. Yeung, E.H.Y. Ng, and P.C. Ho Mitochondrial DNA content and 4977 bp deletion in unfertilized oocytes Mol. Hum. Reprod., December 1, 2005; 11(12): 843 - 846. [Abstract] [Full Text] [PDF]